Article
Oncogenic Mutants of MEK1: A Trilogy Unfolds.
Cancer discovery - 1 May 2018
Maust Joel D, Whitehead Christopher E, Sebolt-Leopold Judith S
Abstract excerpt
<b/> It has generally been assumed that MEK mutants function similarly to one another and respond in the same manner to targeted drugs. Gao and colleagues challenge this assumption and report that MEK1 mutants fall into three unique phenotypic classes with respect to RAF dependency. A new class of MEK1 mutants is shown here to be RAF-independent, resistant to allosteric MEK inhibitors, and yet sensitive to...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
